Clorox Co. (NYSE: CLX) stock fell -1.54% on Monday to $137.03 against a previous-day closing price of $139.17. With 1.3 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.74 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $138.94 whereas the lowest price it dropped to was $136.53. The 52-week range on CLX shows that it touched its highest point at $178.21 and its lowest point at $114.68 during that stretch. It currently has a 1-year price target of $136.58. With its current market cap of 17.00 billion, CLX has annualized dividend of $4.83 while the current yield stands at 3.52%. Beta for the stock currently stands at 0.39.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLX was up-trending over the past week, with a rise of 2.43%, but this was up by 11.59% over a month. Three-month performance dropped to -8.89% while six-month performance fell -15.84%. The stock lost -6.05% in the past year, while it has lost -2.35% so far this year. A look at the trailing 12-month EPS for CLX yields 0.69 with Next year EPS estimates of 5.91. For the next quarter, that number is 1.04. This implies an EPS growth rate of -10.15% for this year and 29.27% for next year. EPS is expected to grow by 6.96% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -28.12%.
Float and Shares Shorts:
At present, 123.82 million CLX shares are outstanding with a float of 123.75 million shares on hand for trading. On Oct 30, 2023, short shares totaled 3.73 million, which was 3.01% higher than short shares on Sep 28, 2023. In addition to Ms. Linda Rendle as the firm’s CEO & Director, Mr. Kevin B. Jacobsen serves as its Executive VP & CFO.
Other institutions hold 50.75% of CLX, in contrast to 43.61% held by mutual funds. Shares owned by individuals account for 38.90%. As the largest shareholder in CLX with 11.94% of the stake, The Vanguard Group, Inc. holds 14,800,477 shares worth 14,800,477. A second-largest stockholder of CLX, SSgA Funds Management, Inc., holds 8,682,301 shares, controlling over 7.00% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in CLX, holding 6,749,383 shares or 5.44% stake. With a 3.13% stake in CLX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 3,874,655 shares are owned by the mutual fund manager. The Vanguard 500 Index Fund, which owns about 2.41% of CLX stock, is the second-largest Mutual Fund holder. It holds 2,989,089 shares valued at 351.82 million. Vanguard Mid Cap Index Fund holds 2.27% of the stake in CLX, owning 2,810,795 shares worth 330.83 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CLX analysts setting a high price target of $169.00 and a low target of $115.00, the average target price over the next 12 months is $136.58. Based on these targets, CLX could surge 23.33% to reach the target high and fall by -16.08% to reach the target low. Reaching the average price target will result in a decline of -0.33% from current levels.
Summary of Insider Activity:
Insiders traded CLX stock several times over the past three months with 9 Buys and 15 Sells. In these transactions, 30,077 shares were bought while 4,129 shares were sold. The number of buy transactions has increased to 14 while that of sell transactions has risen to 21 over the past year. The total number of shares bought during that period was 41,078 while 15,406 shares were sold.